(Arg) 9 - TAMRA labeled

<strong>(Arg)9 - TAMRA labeled</strong>_x000D_ <strong>Catalog number:</strong> B2019446_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> 1836.2_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> TAMRA-RRRRRRRRR_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Shah S, Mandecki W, Li J, Gryczynski Z, Borejdo J, Gryczynski I, Fudala R. FRET study in oligopeptide-linked donor-acceptor system in PVA matrix Methods Appl Fluoresc. 2016 Dec 13;4(4):047002._x000D_ 2: Leung K. Polyethylene glycol-Cys-Arg-Ser-Gly-Pro-Leu-Gly-Val-Tyr-Lys-Lys-tetramethylrhodamine 2012 Feb 6 [updated 2012 May 10]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013._x000D_ 3: Sabourin T, Bastien L, Bachvarov DR, Marceau F. Agonist-induced translocation of the kinin B(1) receptor to caveolae-related rafts Mol Pharmacol. 2002 Mar;61(3):546-53._x000D_ 4: Richard JP, Melikov K, Vives E, Ramos C, Verbeure B, Gait MJ, Chernomordik LV, Lebleu B. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake J Biol Chem. 2003 Jan 3;278(1):585-90._x000D_ 5: Charest-Morin X, Roy C, Fortin EJ, Bouthillier J, Marceau F. Pharmacological evidence of bradykinin regeneration from extended sequences that behave as peptidase-activated B2 receptor agonists Front Pharmacol. 2014 Mar 7;5:32._x000D_ 6: Childs-Disney JL, Parkesh R, Nakamori M, Thornton CA, Disney MD. Rational design of bioactive, modularly assembled aminoglycosides targeting the RNA that causes myotonic dystrophy type 1 ACS Chem Biol. 2012 Dec 21;7(12):1984-93._x000D_ 7: Achilefu S, Srinivasan A, Schmidt MA, Jimenez HN, Bugaj JE, Erion JL. Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors J Med Chem. 2003 Jul 17;46(15):3403-11._x000D_ 8: Ke AQ, Liu AD, Gao YN, Luo DN, Li ZF, Yu YQ, Liu JY, Xu H, Cao X. Development of novel affinity reagents for detecting protein tyrosine phosphorylation based on superbinder SH2 domain in tumor cells Anal Chim Acta. 2018 Nov 22;1032:138-146._x000D_ 9: Saito S, Yokoyama T, Aizawa T, Kawaguchi K, Yamaki T, Matsumoto D, Kamijima T, Kamiya M, Kumaki Y, Mizuguchi M, Takiya S, Demura M, Kawano K. Structural properties of the DNA-bound form of a novel tandem repeat DNA-binding domain, STPR Proteins. 2008 Jul;72(1):414-26._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/26802446">10: Martin RP, Filippelli-Silva R, Rodrigues ES, Nakaie CR, Shimuta SI. A fluorimetric binding assay for angiotensin II and kinin receptors J Pharmacol Toxicol Methods. 2016 May-Jun;79:55-9. </a>_x000D_ _x000D_ <strong>Products Related to (Arg)9 - TAMRA labeled can be found at</strong> <a href="https://moleculardepot.com/product-category/Peptides/"> Peptides</a>